Triazine dyes are agonists of the NAADP receptor.
NAADP has been shown to be a potent calcium-releasing second messenger in a wide variety of cell types to date. However, research has been hampered by a lack of pharmacological agents, with which to investigate NAADP-induced calcium release, and by the molecular identity of its cellular target protein being unknown. In the present paper, the sea urchin egg model was used to investigate whether triazine dyes, which can act as nucleotide mimetics, can bind to the NAADP receptor, induce Ca(2+) release and be used for affinity chromatography of the receptor. Indeed, all the triazine dyes tested (Reactive Red 120 (RR120), Reactive Green 19 (RG19), Reactive Green 5 (RG5), Cibacron Blue 3GA and Reactive Yellow 86) displayed micromolar affinities, except for Reactive Orange 14. Furthermore, unlike NAADP, RR120, RG19 and RG5 did not bind in an irreversible manner. The compound that displayed the highest affinity, RR120, was tested in a (45)Ca(2+) efflux assay. This compound released Ca(2+) via the NAADP receptor, as shown by the ability of subthreshold NAADP concentrations to inhibit this release. Furthermore, heparin and ruthenium red were unable to block RR120-induced Ca(2+) release. We have also shown that RG5 and RG19, immobilised on resins, retain the ability to bind to the receptor, and that this interaction can be disrupted by high salt concentrations. As a proof of principle, we have shown that this can be used to partially purify the NAADP receptor by at least 75-fold. In conclusion, triazine dyes interact with the NAADP receptor, and this could be exploited in future to create a new generation of pharmacological tools to investigate this messenger and, in combination with other techniques, to purify the receptor.
Billington
Richard A
RA
Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD. richard.billington@pharm.unipmn.it
Bak
Judit
J
Martinez-Coscolla
Ana
A
Debidda
Marcella
M
Genazzani
Armando A
AA
D000818:Animals; D004396:Coloring Agents / Q000378:metabolism* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D047331:Lytechinus; D009249:NADP / Q000031:analogs & derivatives* / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists* / Q000032:analysis*; D015290:Second Messenger Systems / Q000187:drug effects / Q000502:physiology; D014227:Triazines / Q000378:metabolism* / Q000494:pharmacology
D004396:Coloring Agents; D018160:Receptors, Cytoplasmic and Nuclear; D014227:Triazines; D009249:NADP; C024376:NAADP